Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000019617-14-000540
Filing Date
2014-12-10
Accepted
2014-12-10 10:20:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 AEGERION.HTM SC 13G/A 36234
  Complete submission text file 0000019617-14-000540.txt   38188
Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVE 38TH FL NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

EIN.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85739 | Film No.: 141276892
SIC: 2834 Pharmaceutical Preparations